Liposomal gels for vaginal drug delivery.

The aim of our study was to develop a liposomal drug carrier system, able to provide sustained and controlled release of appropriate drug for local vaginal therapy. To optimise the preparation of liposomes with regards to size and entrapment efficiency, liposomes containing calcein were prepared by five different methods. Two optimal liposomal preparations (proliposomes and polyol dilution liposomes) were tested for their in vitro stability in media that simulate human vaginal conditions (buffer, pH 4.5). To be closer to in vivo application of liposomes and to achieve further improvement of their stability, liposomes were incorporated in vehicles suitable for vaginal self-administration. Gels of polyacrylate were chosen as vehicles for liposomal preparations. Due to their hydrophilic nature and bioadhesive properties, it was possible to achieve an adequate pH value corresponding to physiological conditions as well as desirable viscosity. In vitro release studies of liposomes incorporated in these gels (Carbopol 974P NF or Carbopol 980 NF) confirmed their applicability as a novel drug carrier system in vaginal delivery. Regardless of the gel used, even 24 h after the incubation of liposomal gel in the buffer pH 4.5 more than 80% of the originally entrapped substance was still retained.

[1]  H. Kikuchi,et al.  A POLYOL DILUTION METHOD FOR MASS PRODUCTION OF LIPOSOMES , 1994 .

[2]  Balram Sahu,et al.  Development of a Liposome Based Contraceptive System for Intravaginal Administration of Progesterone , 1997 .

[3]  M. Foldvari Effect of vehicle on topical liposomal drug delivery: petrolatum bases. , 1996, Journal of microencapsulation.

[4]  J. Robinson,et al.  Vaginal and reproductive system treatments using a bioadhesive polymer , 1994 .

[5]  W. Williams,et al.  A Simple Method for the Preparation of Liposomes for Pharmaceutical Applications: Characterization of the Liposomes , 1991, The Journal of pharmacy and pharmacology.

[6]  J. Bouwstra,et al.  Interactions of external lipids (lipid vesicles) with the skin , 1995 .

[7]  Natas˘a S˘kalko,et al.  Liposomes with Metronidazole for Topical Use: The Choice of Preparation Method and Vehicle , 1998 .

[8]  J. Remon,et al.  Preliminary Efficacy Study of a Bioadhesive Vaginal Metronidazole Tablet in the Treatment of Bacterial Vaginosis , 1995, The Journal of pharmacy and pharmacology.

[9]  N. Škalko-Basnet,et al.  Liposomes Containing Drug and Cyclodextrin Prepared by the One-Step Spray-Drying Method , 2000, Drug development and industrial pharmacy.

[10]  J. Robinson,et al.  Hydrogel delivery systems for vaginal and oral applications: Formulation and biological considerations , 1993 .

[11]  M. Foldvari,et al.  Clinical Observations with Topical Liposome-Encapsulated Interferon Alpha for the Treatment of Genital Papillomavirus Infections , 1997 .

[12]  N. Škalko-Basnet,et al.  Liposomes containing drugs for treatment of vaginal infections. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  F. Szoka,et al.  A simple in vitro model to study the release kinetics of liposome encapsulated material. , 1998, Journal of controlled release : official journal of the Controlled Release Society.